Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 1/2 1

Status

Unknown 3Completed 3Recruiting 2Active not recruiting 2Terminated 1

Sponsor Class

OTHER 3

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Gastrointestinal 57Breast 55Genitourinary 31Gynecologic 28Thoracic 25Dermatologic 22Other hematologic neoplasm 16Lymphoid 16Tumor-Agnostic 14Plasma cell 14Head & Neck 11Myeloid 9CNS 9Sarcoma 8Other solid neoplasm 6Endocrine 3Other neoplasm 2Other 2NET 2Classical hematology 2

Conditions

Thymus Neoplasms 1Parathyroid Diseases 1Pancreatic Neoplasms 1Neuroendocrine Tumors 1Multiple Endocrine Neoplasia Type 1 1Midgut Neuroendocrine Tumors 1

Interventions

Everolimus 32Octreotide 15Cisplatin 14pasireotide 13Sunitinib 13Temozolomide 11pembrolizumab 10Etoposide 10Doxorubicin 10lanreotide 9Magnetic Resonance Spectroscopy 9Bevacizumab 9lutetium Lu 177 dotatate 8gallium Ga 68 dotatate 8Sorafenib 8Paclitaxel 83-Iodobenzylguanidine 8lenvatinib 7pazopanib 6Radiotherapy 6Positron Emission Tomography Computed Tomography 6Nivolumab 6surufatinib 5cabozantinib 5avelumab 5Thyrotropin Alfa 5Surgical Procedures, Operative 5Radiosurgery 5Mitotane 5Irinotecan 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Blood Specimen Collection × Endocrine × Clear all
NCT03667092 2025-04-10

GENEBIOLuNET

University Hospital, Toulouse

Phase NA Completed
47 enrolled
EndocrineNET

Midgut Neuroendocrine Tumors

NCT02348749 2025-03-19

18F-MFBG Imaging for Evaluation of Neuroendocrine Malignancies

Memorial Sloan Kettering Cancer Center

Phase 1/2 Completed
48 enrolled
EndocrineNET

Neuroendocrine Tumors

NCT01794676 2017-06-16

MEN1

Jersey Shore University Medical Center

Completed
9 enrolled
EndocrineGastrointestinalHead & Neck

Pancreatic Neoplasms, Parathyroid Diseases, Thymus Neoplasms, Multiple Endocrine Neoplasia Type 1

Data powered by HemOnc (CC BY 4.0) Colophon âš¡